Literature DB >> 22881232

Peripheral arterial stiffness in primary aldosteronism.

J Rosa1, Z Somlóová, O Petrák, B Strauch, T Indra, M Senitko, T Zelinka, R Holaj, J Widimský.   

Abstract

Aldosterone overproduction increases arterial wall stiffness by accumulation of different types of collagen fibres and growth factors. Our previous studies showed that central (aortic) arterial stiffness is increased in primary aldosteronism (PA) independently of concomitant hypertension and that these changes might be reversible after successful adrenalectomy. There is limited data available on the potential impact of mineralocorticoid overproduction on the deterioration of peripheral arterial stiffness. The current study was thus aimed at investigating the effect of aldosterone overproduction on peripheral arterial stiffness assessed by peripheral (femoral-ankle) pulse wave velocity (PWV) in PA patients compared with essential hypertension (EH) patients. Forty-nine patients with confirmed PA and 49 patients with EH were matched for age, blood pressure, body mass index, lipid profile, and fasting glucose. PWV was obtained using the Sphygmocor applanation tonometer. Both peripheral and central PWV were significantly higher in PA patients compared to EH patients, while clinical blood pressures were similar. Plasma aldosterone level was the main predictor of peripheral PWV in PA. Our data indicate aldosterone overproduction in PA does not preferentially affect central arterial system. Fibroproliferative effect of higher aldosterone levels lead to alteration of central-elastic as well as peripheral-muscular arteries with subsequent increase in its stiffness.

Entities:  

Mesh:

Year:  2012        PMID: 22881232     DOI: 10.33549/physiolres.932344

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  10 in total

1.  Low-Dose Mineralocorticoid Receptor Blockade Prevents Western Diet-Induced Arterial Stiffening in Female Mice.

Authors:  Vincent G DeMarco; Javad Habibi; Guanghong Jia; Annayya R Aroor; Francisco I Ramirez-Perez; Luis A Martinez-Lemus; Shawn B Bender; Mona Garro; Melvin R Hayden; Zhe Sun; Gerald A Meininger; Camila Manrique; Adam Whaley-Connell; James R Sowers
Journal:  Hypertension       Date:  2015-05-26       Impact factor: 10.190

2.  Aldosterone, inactive matrix gla-protein, and large artery stiffness in hypertension.

Authors:  Julio A Chirinos; Mayank Sardana; Amer Ahmed Syed; Maheshwara R Koppula; Swapna Varakantam; Izzah Vasim; Harold G Oldland; Timothy S Phan; Nadja E A Drummen; Cees Vermeer; Raymond R Townsend; Scott R Akers; Wen Wei; Edward G Lakatta; Olga V Fedorova
Journal:  J Am Soc Hypertens       Date:  2018-06-30

3.  Smooth muscle cell mineralocorticoid receptors are mandatory for aldosterone-salt to induce vascular stiffness.

Authors:  Anne Pizard; Alexandre Gueret; Guillaume Galmiche; Soumaya El Moghrabi; Antoine Ouvrard-Pascaud; Stefan Berger; Pascal Challande; Iris Z Jaffe; Carlos Labat; Patrick Lacolley; Frédéric Jaisser
Journal:  Hypertension       Date:  2013-12-02       Impact factor: 10.190

4.  Long-term BP control and vascular health in patients with hyperaldosteronism treated with low-dose, amiloride-based therapy.

Authors:  Joseph L Izzo; Michael Hong; Tanveer Hussain; Peter J Osmond
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-06-06       Impact factor: 3.738

5.  Maintenance of long-term blood pressure control and vascular health by low-dose amiloride-based therapy in hyperaldosteronism.

Authors:  Joseph L Izzo; Michael Hong; Tanveer Hussain; Peter J Osmond
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-07-26       Impact factor: 3.738

6.  Comparisons of microvascular and macrovascular changes in aldosteronism-related hypertension and essential hypertension.

Authors:  Monica Varano; Pierluigi Iacono; Massimiliano M Tedeschi; Claudio Letizia; Mario Curione; Claudio Savoriti; Erika Baiocco; Laura Zinnamosca; Cristiano Marinelli; Barbara Boccassini; Mariacristina Parravano
Journal:  Sci Rep       Date:  2017-06-01       Impact factor: 4.379

Review 7.  Endothelial Dysfunction in Primary Aldosteronism.

Authors:  Zheng-Wei Chen; Cheng-Hsuan Tsai; Chien-Ting Pan; Chia-Hung Chou; Che-Wei Liao; Chi-Sheng Hung; Vin-Cent Wu; Yen-Hung Lin
Journal:  Int J Mol Sci       Date:  2019-10-21       Impact factor: 5.923

8.  Concurrent Primary Aldosteronism and Renal Artery Stenosis: An Overlooked Condition Inducing Resistant Hypertension.

Authors:  Lin Zhao; Jinhong Xue; Yi Zhou; Xueqi Dong; Fang Luo; Xiongjing Jiang; Xinping Du; Xianliang Zhou; Xu Meng
Journal:  Front Cardiovasc Med       Date:  2022-03-03

9.  Relationship between plasma aldosterone levels and arterial stiffness parameters in hypertensive patients with subclinical vascular damage.

Authors:  L Petramala; A Concistrè; M Mezzadri; F Sarlo; F Circosta; M Schina; M Soldini; G Iannucci; C Letizia
Journal:  Int J Cardiol Cardiovasc Risk Prev       Date:  2022-06-06

10.  Time course and factors predicting arterial stiffness reversal in patients with aldosterone-producing adenoma after adrenalectomy: prospective study of 102 patients.

Authors:  Che-Wei Liao; Lian-Yu Lin; Chi-Sheng Hung; Yen-Tin Lin; Yi-Yao Chang; Shuo-Meng Wang; Vin-Cent Wu; Kwan-Dun Wu; Yi-Lwun Ho; Fumitoshi Satoh; Yen-Hung Lin
Journal:  Sci Rep       Date:  2016-02-17       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.